6G: Nanomaterials SIG: Nanomaterials in Health and Disease
Time: 1:30 PM to 3:30 PM
Description
This session is intended to focus on mechanistic aspects of nanomaterial development leading to their application for treatment or diagnoses of disease. We encourage submissions that make the connection between mechanistic observations (such as nanomaterial surface characteristics, formulation approaches, or mode of interaction with cells and tissues) and the outcomes of such systems in vivo. This may include work on targeted delivery, biosensors, therapeutics, imaging agents, or others. The underlying theme for this session focuses on the principal that better understanding of mechanism leads to better material engineering. We welcome abstract submission from all scientific levels (trainee to faculty) and encourage topics that address diseases and topics that are otherwise understudied.
Moderators:
Kelly Langert, Ph.D
Loyola University Chicago
Ester Kwon, Ph.D
Assistant Professor, Bioengineering
Sanford Consortium for Regenerative Medicine
1:30 PM. 324. Polycatecholic Nanoparticles to Restore Macrophage Homeostasis in Aged Microenvironments.Cameron Moore, M.S.1, Danielle Benoit1 1University of Oregon
2:00 PM. 326. Unraveling Nanospiral Morphology Mechanism in Self-Assembling Peptide Hydrogels.Paul Eisold1, Jonathan Florian, B.S.1, Diana Kirilov2, Justin Kim3, Kyle Lampe, PhD1 1University of Virginia, 2Merck, 3University of Florida
Combining Enzymes and Oxygen-Responsive Phosphorescent Nanoparticles to Engineering a Chemo-Optical Phosphate Biosensor for Hyperphosphatemia Management.Su Jeong Ahn, Graduate student1, Daniel Alge, PhD1, Michael McShane, PhD1 1Texas A&M University
E2:45 PM. 329. ngineering protein-based nanoparticle stability through tunable hysteretic phase separation behaviors.Alexa Regina Avecilla1, Felipe Quiroz, PhD1 1Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University